![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SOLVAY SEIYAKU, EISAI COLLABORATE ON SA-001
SOLVAY SEIYAKU, EISAI COLLABORATE ON SA-001
Switzerland-based Solvay Pharmaceuticals Marketing & Licensing AG, an affiliate of Solvay Pharmaceuticals (Brussels, Belgium) and Eisai Co. Ltd. concluded a license agreement on Solvay Pharmaceuticals' treatment for pancreatic exocrine insufficiency (SA-001) in Japan.
BioSpectrum (http://www.biospectrumasia.com/content/270706JPN1232.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct